According to Altimmune's latest financial reports the company's current revenue (TTM ) is โฌ0.01 Million. a decrease over the revenue in the year 2023 that were of โฌ0.38 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โฌ0.01 M | -95.01% |
2023 | โฌ0.38 M | -707.89% |
2022 | -โฌ0.07 Million | -101.63% |
2021 | โฌ3.89 M | -41.47% |
2020 | โฌ6.65 M | 28.5% |
2019 | โฌ5.17 M | -67.19% |
2018 | โฌ15.78 M | 45536.76% |
2017 | โฌ0.03 M | -98.41% |
2016 | โฌ2.17 M | -77.64% |
2015 | โฌ9.73 M | 16.15% |
2014 | โฌ8.37 M | -35.4% |
2013 | โฌ12.97 M | -31.85% |
2012 | โฌ19.03 M | 1.86% |
2011 | โฌ18.68 M | 18.39% |
2010 | โฌ15.78 M | -17.92% |
2009 | โฌ19.22 M | -18.32% |
2008 | โฌ23.54 M | 136.21% |
2007 | โฌ9.96 M | 863.56% |
2006 | โฌ1.03 M |